-
Reminder – PTC Therapeutics Webinar Tonight
Tonight at 7pm EST, PTC Therapeutics will be hosting an Informational Patient Webinar to learn more about FA-743, a candidate molecule for the treatment of Friedreich’s Ataxia.
The clinical trial for FA-743 will be international and include clinic sites in Australia, Brazil, Canada, the E.U., and the U.S.
To pre-register for the webinar, please click here: https://us02web.zoom.us/webinar/register/WN_Btin1uiUQKWkxU2Fjuz5lw
Sorry, there were no replies found.
Log in to reply.